Skip to main content
NVDA+0.88%AAPL+0.82%MSFT+0.11%GOOGL+1.59%AMZN+1.77%TSM+2.90%SPCX+2.62%AVGO+4.04%META-0.92%TSLA+3.57%LLY+0.02%BRK-B-0.65%MU+2.94%SKHY+2.61%WMT-0.96%AMD+5.23%JPM+0.64%V-0.80%XOM-1.90%JNJ+0.38%ASMLa+2.84%MA-0.47%ABBV+0.09%INTC+3.75%1398.HK+2.15%CVX-1.73%0700.HK-0.31%COST-1.27%CSCO+1.86%KO-0.74%ORCL+4.56%UNH-0.27%PG-0.74%BAC+0.35%1816.HK+1.32%3988.HK+0.66%CAT+2.69%DELL+8.20%HD-0.26%PM+0.74%0857.HK-0.98%0939.HK+0.81%AMAT+2.36%AP2d+2.44%GE+3.22%1288.HK+0.60%LRCX+1.40%0005.HK-5.56%NVS+1.15%MS+1.99%USDJPY+0.65%NZDMXN+0.63%AUDJPY+0.60%EURUSD-0.53%GBPUSD-0.51%USDMXN+0.50%EURSEK-0.49%EURZAR-0.49%GBPZAR-0.48%AUDDKK+0.48%EURAUD-0.47%NZDJPY+0.46%GBPAUD-0.44%USDCHF+0.44%GBPTRY+0.41%AUDCHF+0.39%CADJPY+0.37%EURNZD-0.35%EURCNH-0.34%CHFSEK-0.33%GBPHKD+0.32%GBPNZD-0.30%USDCAD+0.30%EURHKD-0.29%GBPMXN-0.28%USDDKK+0.28%EURSGD-0.27%GBPSGD-0.27%AUDNOK+0.25%NZDCHF+0.24%SGDJPY+0.24%AUDCAD+0.23%CHFJPY+0.23%EURNOK-0.23%GBPCAD-0.22%EURCAD-0.22%USDSEK-0.22%USDZAR-0.21%AUDSGD+0.20%NZDUSD-0.20%NOKJPY+0.20%USDTRY+0.18%USDILS+0.16%EURPLN-0.15%CADCHF+0.14%NZDSGD+0.14%GBPJPY+0.14%EURJPY+0.13%USDPLN+0.13%AUDNZD+0.13%PLNJPY+0.12%EURCHF-0.11%CHFSGD-0.10%NZDCAD+0.10%EURCZK-0.09%GBPCHF-0.08%AUDUSD-0.06%CHFNOK-0.05%USDNOK+0.05%USDCNH-0.05%USDCOP-0.04%USDHKD+0.04%EURGBP-0.02%USDSGD0.00%EURDKK0.00%USDTHB0.00%COCOA+1.68%HG1+1.64%COFFEE-1.47%USOIL-1.17%GAUUSD+1.02%XAUUSD+1.02%COTTON-0.95%XAGUSD+0.82%GAGUSD+0.82%UKOIL-0.76%S1-0.69%C1-0.63%BTCUSD+0.74%ETHUSD+23.96%USDTUSD+0.04%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.30%ZECUSDT+6.74%DOGEUSD+20.65%XMRUSDT-0.72%LINKUSD+25.58%BCHUSDT+3.51%XLMUSD+0.28%UNIUSD+0.64%LTCUSD+17.89%SUIUSD+1.18%HBARUSDT-1.04%TONUSD+41.71%TAOUSDT+0.77%AAVEUSD-1.76%DOTUSDT-1.29%ICPUSDT-1.37%ONDOUSDT+0.80%WLDUSDT+1.06%ARBUSDT+0.37%JUPUSDT+1.02%INJUSDT+1.81%ATOMUSDT-0.76%STXUSDT-0.75%TIAUSDT-1.98%FETUSDT+3.93%PYTHUSDT-3.55%SEIUSDT+0.54%IMXUSDT+0.43%GRTUSDT+2.01%OPUSDT-0.20%WIFUSDT-0.61%IOTAUSDT+1.06%POLUSDT+0.29%AXSUSDT+0.72%EOSUSDT+0.98%FARTCOINUSDT+2.47%DYDXUSDT+2.14%GALAUSDT+0.41%ORDIUSDT+2.05%RONINUSDT+1.89%NOTUSDT+1.92%NVDA+0.88%AAPL+0.82%MSFT+0.11%GOOGL+1.59%AMZN+1.77%TSM+2.90%SPCX+2.62%AVGO+4.04%META-0.92%TSLA+3.57%LLY+0.02%BRK-B-0.65%MU+2.94%SKHY+2.61%WMT-0.96%AMD+5.23%JPM+0.64%V-0.80%XOM-1.90%JNJ+0.38%ASMLa+2.84%MA-0.47%ABBV+0.09%INTC+3.75%1398.HK+2.15%CVX-1.73%0700.HK-0.31%COST-1.27%CSCO+1.86%KO-0.74%ORCL+4.56%UNH-0.27%PG-0.74%BAC+0.35%1816.HK+1.32%3988.HK+0.66%CAT+2.69%DELL+8.20%HD-0.26%PM+0.74%0857.HK-0.98%0939.HK+0.81%AMAT+2.36%AP2d+2.44%GE+3.22%1288.HK+0.60%LRCX+1.40%0005.HK-5.56%NVS+1.15%MS+1.99%USDJPY+0.65%NZDMXN+0.63%AUDJPY+0.60%EURUSD-0.53%GBPUSD-0.51%USDMXN+0.50%EURSEK-0.49%EURZAR-0.49%GBPZAR-0.48%AUDDKK+0.48%EURAUD-0.47%NZDJPY+0.46%GBPAUD-0.44%USDCHF+0.44%GBPTRY+0.41%AUDCHF+0.39%CADJPY+0.37%EURNZD-0.35%EURCNH-0.34%CHFSEK-0.33%GBPHKD+0.32%GBPNZD-0.30%USDCAD+0.30%EURHKD-0.29%GBPMXN-0.28%USDDKK+0.28%EURSGD-0.27%GBPSGD-0.27%AUDNOK+0.25%NZDCHF+0.24%SGDJPY+0.24%AUDCAD+0.23%CHFJPY+0.23%EURNOK-0.23%GBPCAD-0.22%EURCAD-0.22%USDSEK-0.22%USDZAR-0.21%AUDSGD+0.20%NZDUSD-0.20%NOKJPY+0.20%USDTRY+0.18%USDILS+0.16%EURPLN-0.15%CADCHF+0.14%NZDSGD+0.14%GBPJPY+0.14%EURJPY+0.13%USDPLN+0.13%AUDNZD+0.13%PLNJPY+0.12%EURCHF-0.11%CHFSGD-0.10%NZDCAD+0.10%EURCZK-0.09%GBPCHF-0.08%AUDUSD-0.06%CHFNOK-0.05%USDNOK+0.05%USDCNH-0.05%USDCOP-0.04%USDHKD+0.04%EURGBP-0.02%USDSGD0.00%EURDKK0.00%USDTHB0.00%COCOA+1.68%HG1+1.64%COFFEE-1.47%USOIL-1.17%GAUUSD+1.02%XAUUSD+1.02%COTTON-0.95%XAGUSD+0.82%GAGUSD+0.82%UKOIL-0.76%S1-0.69%C1-0.63%BTCUSD+0.74%ETHUSD+23.96%USDTUSD+0.04%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.30%ZECUSDT+6.74%DOGEUSD+20.65%XMRUSDT-0.72%LINKUSD+25.58%BCHUSDT+3.51%XLMUSD+0.28%UNIUSD+0.64%LTCUSD+17.89%SUIUSD+1.18%HBARUSDT-1.04%TONUSD+41.71%TAOUSDT+0.77%AAVEUSD-1.76%DOTUSDT-1.29%ICPUSDT-1.37%ONDOUSDT+0.80%WLDUSDT+1.06%ARBUSDT+0.37%JUPUSDT+1.02%INJUSDT+1.81%ATOMUSDT-0.76%STXUSDT-0.75%TIAUSDT-1.98%FETUSDT+3.93%PYTHUSDT-3.55%SEIUSDT+0.54%IMXUSDT+0.43%GRTUSDT+2.01%OPUSDT-0.20%WIFUSDT-0.61%IOTAUSDT+1.06%POLUSDT+0.29%AXSUSDT+0.72%EOSUSDT+0.98%FARTCOINUSDT+2.47%DYDXUSDT+2.14%GALAUSDT+0.41%ORDIUSDT+2.05%RONINUSDT+1.89%NOTUSDT+1.92%
NE

NeuroPace, Inc. (NPCE)

NASDAQ • Healthcare

$12.99
+$0.08 (+0.6%)
Market open

Last close at October 26, 2026 at 20:00 UTC

Open$12.9
Previous Close$12.99
Day Range$12.64 - $13.22
Avg. Volume (3M)106.9K
Market Cap$446.2M
52 Week Range
$9.22$19.6
Next EarningsIn 7 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$22.8M100%
Gross Profitminus cost of goods$18.9M83%

In plain terms: out of every $100 in revenue, NeuroPace, Inc. currently loses $27.

Fundamentals & Financials

Revenue (TTM)
$98.8M
Net Income (TTM)
-$19.1M
EPS (TTM)
-$0.57
ROA (TTM)
-19.71%
Current Ratio
4.94

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+42.9%Q1 2026-$0.08
-5.3%Q2 2026-$0.2
+17.4%Q3 2026-$0.18
Next

Nov 3

in 7 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +17.4%

NeuroPace topped EPS expectations while revenue came in line in the second fiscal quarter of 2026, reported August 11, 2026, as revenue slipped 3.0% to about $22.8 million (down from $23.5 million a year ago) and EPS of -$0.18 topped the -$0.22 estimate by $0.04. Gross profit was roughly $18.9 million, with gross margin at about 82.8%, while operating results remained negative with operating income of about -$5.1 million and an operating margin near -22.5%. Net income improved 28.3% year over year to roughly -$6.2 million (from -$8.7 million), alongside EPS up from -$0.26 a year ago. Cash generation was also negative, with negative operating cash flow of about $3.9 million. For the next period, consensus calls for EPS of -$0.11 on revenue of $27.1 million.

Next report — what to expect

NeuroPace, Inc. (NPCE) reports earnings on November 3, 2026. Wall Street is looking for EPS of -$0.114 on revenue of $27.1 million; for trailing context, revenue was down -3.0% year over year last quarter. NeuroPace has beaten EPS in 6 of 8 most recent quarters.

View full earnings history

About NeuroPace, Inc.

NeuroPace, Inc. develops implantable neuromodulation technology for epilepsy care and trades on NASDAQ as NPCE. The healthcare company works in medical devices, centered on the RNS system for drug-resistant focal epilepsy, and generated $100.0 million of revenue in FY2025 across its United States hospital-facility customer base.

Name
NeuroPace, Inc.
CEO
Joel D. Becker
Website
www.neuropace.com
Industry
Healthcare
Year Founded
1997
Employees
220

Today's Snapshot

AI-generated

NPCE opened 1.7% higher at 13.21, in line with a flat sector. Earnings are due from NPCE on 3 November.

Trading Volume

Below 10d avg (87.0K)

3.9K

vs S&P 500 Today

Moderate Underperformance

-0.42%

Updated: October 27, 2026 at 14:43 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
NPCE shows a weak trend environment with ADX indicating low directional strength while price sits near short-term averages but below most longer-term moving averages, which weigh on the outlook. Momentum readings are mixed: RSI and MACD are neutral to slightly negative, while a small positive momentum print and rising OBV provide limited support. Volatility is moderate and unchanged, and the classic pivot sits essentially at today's price, offering little directional guidance. Overall, the balance of indicators favors caution and a modest bearish bias. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$12.97 - $14.63
    Sell
  • RSI (14)46.83
    Neutral
  • Stochastic %K (14, 3, 3)53.42
    Neutral
  • MACD Level (12, 26)-0.23
    Neutral

Peers & Related Assets

CVRXCVRx, Inc.
$1.45+2.1%
MOBIMobia Medical, Inc. Common Stock
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.